Nephrolyx is the leading provider of GFR measurement in clinical routine. The company builds on 12 years of research in the field of kidney function diagnostics at Charité Universitätsmedizin Berlin.
Nephrolyx’s mission is to optimize patient outcomes by providing physicians and researchers with access to GFR measurement. Addressing challenges in kidney diagnostics, the company thoroughly works to enhance patient treatment in both hospital and ambulatory settings.
Moreover, Nephrolyx is dedicated to fostering innovation in the field, supporting the development of new medications and assisting pharma and biotech companies in kidney research and clinical trials. The company aims to enable precision medicine in healthcare worldwide.